SNORA66: A Potential Drug Target and Biomarker (G26782)

Target Name: SNORA66

NCBI ID: G26782

SNORA66

Other Name(s): small nucleolar RNA, H/ACA box 66 | U66 | RNU66 | Small nucleolar RNA, H/ACA box 66

SNORA66: A Potential Drug Target and Biomarker

Small nucleolar RNA (snRNA) is a class of non-coding RNAs that play a critical role in regulating gene expression in eukaryotic cells. One of the most well-known snRNAs is H/ACA box 66 (SNORA66), which is expressed in high levels in various tissues and is involved in the regulation of various cellular processes.

SNORA66 is a member of the H/ACA box family, which includes several other snRNAs that share a conserved core sequence responsible for their unique structure and function. These snRNAs are characterized by the presence of a highly conserved H/ACA box, which is a region of approximately 120 amino acids that is critical for the stability and function of the RNA molecule. The H/ACA box is a common feature in many snRNAs and is thought to play a role in the regulation of various cellular processes, including gene expression, RNA stability, and post-transcriptional modification.

SNORA66 is a non-coding RNA that is expressed in various tissues, including muscle, heart, liver, and brain. It is highly expressed in muscle and heart tissue and is also found in higher concentrations in the liver and brain. SNORA66 has been shown to play a role in the regulation of gene expression and has been identified as a potential drug target.

One of the key functions of SNORA66 is its role in the regulation of protein synthesis. SNORA66 is known to interact with the protein translation factor, ISF3, and it has been shown to play a role in the regulation of ISF3-mediated protein synthesis. ISF3 is a non-coding RNA molecule that is involved in the regulation of protein synthesis and translation. It has been shown to play a role in the regulation of various cellular processes, including cell growth, survival, and reproduction.

SNORA66 has also been shown to play a role in the regulation of RNA stability. RNA stability is critical for the regulation of gene expression and is often regulated by various RNA-proteasome interactions. SNORA66 has been shown to interact with the protein Trrm1, which is involved in the regulation of RNA stability. Trrm1 is a non-coding RNA molecule that is known to play a role in the regulation of protein translation and stability.

In addition to its role in the regulation of protein synthesis and RNA stability, SNORA66 has also been shown to play a role in the regulation of cellular processes that are critical for cell survival. For example, SNORA66 has been shown to play a role in the regulation of cellular apoptosis, which is a critical process that is involved in the regulation of cell death and survival.

SNORA66 has also been shown to play a role in the regulation of cellular signaling pathways. SNORA66 has been shown to interact with the protein FGF1, which is involved in the regulation of cellular signaling pathways. FGF1 is a non-coding RNA molecule that is known to play a role in the regulation of cell growth, survival, and development.

SNORA66 is a small non-coding RNA molecule that has been shown to play a critical role in the regulation of various cellular processes. Its unique structure and function, as well as its potential as a drug target, make SNORA66 an attractive candidate for further research and potential therapeutic applications.

Protein Name: Small Nucleolar RNA, H/ACA Box 66

The "SNORA66 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORA66 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets